BlackRock Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$212K Sell
19,517
-208
-1% -$2.12K ﹤0.01% 2689
2016
Q3
$185K Buy
19,725
+3,096
+19% +$24.9K ﹤0.01% 2729
2016
Q2
$92K Buy
16,629
+61
+0.4% +$394 ﹤0.01% 3008
2016
Q1
$122K Buy
16,568
+209
+1% +$1.42K ﹤0.01% 2828
2015
Q4
$117K Sell
16,359
-7,587
-32% -$61.5K ﹤0.01% 2850
2015
Q3
$186K Sell
23,946
-496
-2% -$4.08K ﹤0.01% 2764
2015
Q2
$236K Buy
24,442
+427
+2% +$3.96K ﹤0.01% 2707
2015
Q1
$178K Buy
24,015
+4,127
+21% +$30.2K ﹤0.01% 2745
2014
Q4
$181K Sell
19,888
-1,103
-5% -$10.7K ﹤0.01% 2690
2014
Q3
$223K Sell
20,991
-256
-1% -$3.04K ﹤0.01% 2546
2014
Q2
$357K Sell
21,247
-2,938
-12% -$48.3K ﹤0.01% 2259
2014
Q1
$455K Buy
24,185
+1,544
+7% +$24.9K ﹤0.01% 2110
2013
Q4
$367K Buy
22,641
+1,526
+7% +$20.4K ﹤0.01% 2269
2013
Q3
$286K Buy
21,115
+337
+2% +$3.96K ﹤0.01% 2310
2013
Q2
$211K Buy
+20,778
New +$168K ﹤0.01% 2439

Other funds holding STAA

BlackRock Advisors's STAA Position: Q4 2016 in Review

BlackRock Advisors reduced its STAAR Surgical (STAA) stake by 1.1% in Q4 2016, selling an estimated $2.12K and leaving 19,517 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #2689.

BlackRock Advisors first reported a position in STAA in Q2 2013 and has held it in 15 quarters since. The position peaked at $455K in Q1 2014. 80 funds tracked by Wall St. Rank hold STAA as of Q4 2016.

  • BlackRock Advisors held 19,517 shares of STAAR Surgical worth $212K as of Q4 2016.
  • BlackRock Advisors sold 208 STAAR Surgical shares in Q4 2016, an estimated $2.12K.
  • STAAR Surgical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2689 holding.
  • BlackRock Advisors first reported a position in STAAR Surgical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's STAAR Surgical position peaked at $455K in Q1 2014.
  • 80 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.